These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30776137)

  • 1. Parvovirus B19-induced severe anemia in heart transplant recipients: Case report and review of the literature.
    Pinto NC; Newman C; Gomez CA; Khush KK; Moayedi Y; Lee R; Teuteberg JJ; Montoya JG
    Clin Transplant; 2019 Apr; 33(4):e13498. PubMed ID: 30776137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19-Associated Severe Anemia in Adult Liver Transplant Recipients: A Case Series and Review of the Literature.
    Cheng P; Jian Q; Fu Z; Ma Y
    Surg Infect (Larchmt); 2022 Nov; 23(9):848-856. PubMed ID: 36269593
    [No Abstract]   [Full Text] [Related]  

  • 3. Parvovirus B19-induced severe anemia in heart transplant recipient: A case report.
    Xu B; Zhang W; Qian X; Wang S; He F
    Medicine (Baltimore); 2021 Dec; 100(51):e28387. PubMed ID: 34941171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
    Plentz A; Würdinger M; Kudlich M; Modrow S
    J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.
    Würdinger M; Modrow S; Plentz A
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28608818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?
    Gosset C; Viglietti D; Hue K; Antoine C; Glotz D; Pillebout E
    Transpl Infect Dis; 2012 Oct; 14(5):E64-70. PubMed ID: 22931551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
    Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
    J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.
    Porignaux R; Vuiblet V; Barbe C; Nguyen Y; Lavaud S; Toupance O; Andréoletti L; Rieu P; Lévêque N
    J Med Virol; 2013 Jun; 85(6):1115-21. PubMed ID: 23588740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature.
    Wicki J; Samii K; Cassinotti P; Voegeli J; Rochat T; Beris P
    Hematol Cell Ther; 1997 Aug; 39(4):199-204. PubMed ID: 9352328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 infection in kidney transplant recipients: A prospective study in a teaching hospital in Shanghai, China.
    Huang Q; Wang Y; Chen R; Zhao Y; Wang H; Ma X; Li D; Liu Q; Chen X; He L; Zhang M; Li M
    Transpl Immunol; 2022 Oct; 74():101667. PubMed ID: 35835294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.
    Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E
    Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia.
    Ahmed W; Dogar RUH; Acharya S
    J Coll Physicians Surg Pak; 2017 Dec; 27(12):785-787. PubMed ID: 29185410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
    Voleva S; Ivanova S; Marinov B; Genova-Kalou P; Manolov V; Vasilev V
    Akush Ginekol (Sofiia); 2016; 55(3):30-9. PubMed ID: 27514136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.
    Park JB; Kim DJ; Woo SY; Choi GS; Chun JM; Jung GO; Kwon CH; Kim SJ; Joh JW; Lee SK
    Transpl Int; 2009 Apr; 22(4):455-62. PubMed ID: 19144091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 infection and severe anemia in renal transplant recipients.
    Carraturo A; Catalani V; Ottaviani D; Menichelli P; Rossini M; Terella D; Biondi B
    ScientificWorldJournal; 2012; 2012():102829. PubMed ID: 22619569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B19 virus infection in renal transplant recipients.
    Cavallo R; Merlino C; Re D; Bollero C; Bergallo M; Lembo D; Musso T; Leonardi G; Segoloni GP; Ponzi AN
    J Clin Virol; 2003 Apr; 26(3):361-8. PubMed ID: 12637086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts.
    Pedranti MS; Rodriguez-Lombardi G; Bracciaforte R; Romano N; Lujan P; Ricchi B; Mautino J; Adamo MP
    J Med Microbiol; 2017 Dec; 66(12):1715-1721. PubMed ID: 29095139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin.
    Moudgil A; Shidban H; Nast CC; Bagga A; Aswad S; Graham SL; Mendez R; Jordan SC
    Transplantation; 1997 Dec; 64(12):1847-50. PubMed ID: 9422430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.